Being the most active enzyme in converting procarcinogens into active compounds, CYP1A1 promotes the formation of DNA adducts [17, 18] and bioactivation of exogenous procarcinogens of HCC [19]. The gene discussed is CYP1A1; the disease is hepatocellular carcinoma.